{"id":20102,"date":"2024-05-22T09:48:04","date_gmt":"2024-05-22T09:48:04","guid":{"rendered":"https:\/\/carma.com\/?p=20102"},"modified":"2024-05-22T12:32:51","modified_gmt":"2024-05-22T12:32:51","slug":"novo-nordisk-uae-insights","status":"publish","type":"post","link":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/","title":{"rendered":"Insights into Novo Nordisk\u2019s Operations and Strategies in the UAE Market"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">In a recent interview on Dubai Eye 103.8, Mads Bo Larsen, Vice President and General Manager of Novo Nordisk UAE, discussed the company\u2019s operations, volume, and growth. Here are the key points from the interview:\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-significant-growth\">Significant Growth\u00a0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Novo Nordisk is experiencing remarkable growth, with demand increasing by 20 to 30 percent. This growth extends beyond specific products like Wegovy and Ozempic, encompassing Novo Nordisk\u2019s entire product portfolio, including insulin. The surge in demand is partly related to the COVID-19 pandemic.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-impact-of-covid-19-and-challenges-in-product-delivery\">Impact of COVID-19 and Challenges in Product Delivery\u00a0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The pandemic heightened awareness of the importance of treating diabetes to prevent severe complications from COVID-19. Consequently, demand for Novo Nordisk\u2019s products has risen significantly. During 2022 and 2023, Novo Nordisk faced challenges in meeting product demand. However, the company has since scaled up production, ensuring effective delivery.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-communication-strategy\">Communication Strategy\u00a0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">There are concerns about off-label usage of Ozempic for weight loss. Balancing weight loss benefits with proper diabetes treatment remains a priority. Novo Nordisk emphasizes clear communication with healthcare professionals and pharmacies. Ensuring appropriate Ozempic use for diabetes treatment (rather than weight loss) is crucial.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-uae-market-prioritisation-amp-manufacturing-considerations\">UAE Market Prioritisation &amp; Manufacturing Considerations\u00a0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Discussions about local manufacturing have arisen, but the biotechnological complexity and scale required pose challenges. Establishing local facilities remains a topic of interest. The UAE stands out as a prioritised market for Novo Nordisk due to its rapid adoption of new treatments and innovations in healthcare.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-reception-and-competitor-interest\">Market Reception and Competitor Interest\u00a0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-market-reception\">Market Reception:\u00a0<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The market received Novo Nordisk\u2019s announcements positively, with analysts noting the strategic importance of the MENA region for the company\u2019s growth (<a href=\"https:\/\/medriva.com\/business\/novo-nordisks-strategic-moves-2024-share-buyback-program-and-expansion-plans\/\" target=\"_blank\" rel=\"noreferrer noopener\">Medriva<\/a>) (<a href=\"https:\/\/medicalxpress.com\/news\/2024-01-weight-loss-drug-maker-novo.html\" target=\"_blank\" rel=\"noreferrer noopener\">MedXpress<\/a>) (<a href=\"https:\/\/www.fiercepharma.com\/pharma\/novo-keeps-glp-1-expansion-spree-rolling-23b-manufacturing-upgrade-france\" target=\"_blank\" rel=\"noreferrer noopener\">Fierce Pharma<\/a>).\u00a0<\/li>\n\n\n\n<li>Novo Nordisk\u2019s strategic moves, such as its recent share buyback program and significant investments in production capacity, reflect its strong financial position and confidence in future prospects (<a href=\"https:\/\/medriva.com\/business\/novo-nordisks-strategic-moves-2024-share-buyback-program-and-expansion-plans\/\" target=\"_blank\" rel=\"noreferrer noopener\">Medriva<\/a>) (<a href=\"https:\/\/www.marketscreener.com\/quote\/stock\/NOVO-NORDISK-A-S-1412980\/news\/Novo-Nordisk-Invests-DKK-15-9-Billion-in-Expansion-of-Manufacturing-Facilities-in-Hillerod-Denmark-44090619\/\" target=\"_blank\" rel=\"noreferrer noopener\">MarketScreener<\/a>).\u00a0<\/li>\n\n\n\n<li>The expansion and new investments have been well-received, contributing to an optimistic outlook among investors and stakeholders (<a href=\"https:\/\/medicalxpress.com\/news\/2024-01-weight-loss-drug-maker-novo.html\" target=\"_blank\" rel=\"noreferrer noopener\">MedXpress<\/a>) (<a href=\"https:\/\/www.fiercepharma.com\/pharma\/novo-keeps-glp-1-expansion-spree-rolling-23b-manufacturing-upgrade-france\" target=\"_blank\" rel=\"noreferrer noopener\">Fierce Pharma<\/a>).\u00a0<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-competitor-reaction\">Competitor Reaction:\u00a0<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Competitors like Eli Lilly are closely monitoring Novo Nordisk\u2019s expansion. Eli Lilly, for instance, has also been aggressively expanding its manufacturing capabilities to meet rising demand for similar products (<a href=\"https:\/\/www.fiercepharma.com\/pharma\/novo-keeps-glp-1-expansion-spree-rolling-23b-manufacturing-upgrade-france\" target=\"_blank\" rel=\"noreferrer noopener\">Fierce Pharma<\/a>).\u00a0<\/li>\n\n\n\n<li>Increased competition is expected as other pharmaceutical companies respond by bolstering their presence and forming local partnerships in the MENA region (<a href=\"https:\/\/www.fiercepharma.com\/pharma\/novo-keeps-glp-1-expansion-spree-rolling-23b-manufacturing-upgrade-france\" target=\"_blank\" rel=\"noreferrer noopener\">Fierce Pharma<\/a>).\u00a0<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-conclusion\">Conclusion\u00a0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Novo Nordisk\u2019s growth in the UAE is driven by increased demand and effective market strategies. Despite challenges in local manufacturing, the UAE remains a priority due to its rapid adoption of new treatments.\u202f&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a recent interview on Dubai Eye 103.8, Mads Bo Larsen, Vice President and General Manager of Novo Nordisk UAE, discussed the company\u2019s operations, volume, and growth. Here are the key points from the interview:\u00a0 Significant Growth\u00a0 Novo Nordisk is experiencing remarkable growth, with demand increasing by 20 to 30 percent. This growth extends beyond [&hellip;]<\/p>\n","protected":false},"author":60,"featured_media":20103,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[356],"creator":[],"class_list":["post-20102","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-in-the-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Insights into Novo Nordisk\u2019s Operations and Strategies in the UAE Market - CARMA<\/title>\n<meta name=\"description\" content=\"On Dubai Eye 103.8, Mads Bo Larsen, VP and GM of Novo Nordisk UAE, discussed their operations, volume, and growth. Read the key points!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insights into Novo Nordisk\u2019s Operations and Strategies in the UAE Market\" \/>\n<meta property=\"og:description\" content=\"On Dubai Eye 103.8, Mads Bo Larsen, VP and GM of Novo Nordisk UAE, discussed their operations, volume, and growth. Read the key points!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/\" \/>\n<meta property=\"og:site_name\" content=\"CARMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CARMAGlobal\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-22T09:48:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-22T12:32:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/carma.com\/wp-content\/uploads\/2024\/05\/shutterstock_1922901656-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Puneet Sharma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Insights into Novo Nordisk\u2019s Operations and Strategies in the UAE Market\" \/>\n<meta name=\"twitter:description\" content=\"On Dubai Eye 103.8, Mads Bo Larsen, VP and GM of Novo Nordisk UAE, discussed their operations, volume, and growth. Read the key points!\" \/>\n<meta name=\"twitter:creator\" content=\"@CARMA\" \/>\n<meta name=\"twitter:site\" content=\"@CARMA\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Puneet Sharma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Insights into Novo Nordisk\u2019s Operations and Strategies in the UAE Market - CARMA","description":"On Dubai Eye 103.8, Mads Bo Larsen, VP and GM of Novo Nordisk UAE, discussed their operations, volume, and growth. Read the key points!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/","og_locale":"pt_PT","og_type":"article","og_title":"Insights into Novo Nordisk\u2019s Operations and Strategies in the UAE Market","og_description":"On Dubai Eye 103.8, Mads Bo Larsen, VP and GM of Novo Nordisk UAE, discussed their operations, volume, and growth. Read the key points!","og_url":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/","og_site_name":"CARMA","article_publisher":"https:\/\/www.facebook.com\/CARMAGlobal\/","article_published_time":"2024-05-22T09:48:04+00:00","article_modified_time":"2024-05-22T12:32:51+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/carma.com\/wp-content\/uploads\/2024\/05\/shutterstock_1922901656-scaled.jpg","type":"image\/jpeg"}],"author":"Puneet Sharma","twitter_card":"summary_large_image","twitter_title":"Insights into Novo Nordisk\u2019s Operations and Strategies in the UAE Market","twitter_description":"On Dubai Eye 103.8, Mads Bo Larsen, VP and GM of Novo Nordisk UAE, discussed their operations, volume, and growth. Read the key points!","twitter_creator":"@CARMA","twitter_site":"@CARMA","twitter_misc":{"Escrito por":"Puneet Sharma","Tempo estimado de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/#article","isPartOf":{"@id":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/"},"author":{"name":"Puneet Sharma","@id":"https:\/\/carma.com\/pt-pt\/#\/schema\/person\/d9308d8a2da3357eedaaa554e319a674"},"headline":"Insights into Novo Nordisk\u2019s Operations and Strategies in the UAE Market","datePublished":"2024-05-22T09:48:04+00:00","dateModified":"2024-05-22T12:32:51+00:00","mainEntityOfPage":{"@id":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/"},"wordCount":422,"commentCount":0,"publisher":{"@id":"https:\/\/carma.com\/pt-pt\/#organization"},"image":{"@id":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/#primaryimage"},"thumbnailUrl":"https:\/\/carma.com\/wp-content\/uploads\/2024\/05\/shutterstock_1922901656-scaled.jpg","keywords":["In The News"],"articleSection":["Uncategorized"],"inLanguage":"pt-PT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/","url":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/","name":"Insights into Novo Nordisk\u2019s Operations and Strategies in the UAE Market - CARMA","isPartOf":{"@id":"https:\/\/carma.com\/pt-pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/#primaryimage"},"image":{"@id":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/#primaryimage"},"thumbnailUrl":"https:\/\/carma.com\/wp-content\/uploads\/2024\/05\/shutterstock_1922901656-scaled.jpg","datePublished":"2024-05-22T09:48:04+00:00","dateModified":"2024-05-22T12:32:51+00:00","description":"On Dubai Eye 103.8, Mads Bo Larsen, VP and GM of Novo Nordisk UAE, discussed their operations, volume, and growth. Read the key points!","breadcrumb":{"@id":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/#primaryimage","url":"https:\/\/carma.com\/wp-content\/uploads\/2024\/05\/shutterstock_1922901656-scaled.jpg","contentUrl":"https:\/\/carma.com\/wp-content\/uploads\/2024\/05\/shutterstock_1922901656-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/carma.com\/pt-pt\/novo-nordisk-uae-insights\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/carma.com\/pt-pt\/"},{"@type":"ListItem","position":2,"name":"Insights into Novo Nordisk\u2019s Operations and Strategies in the UAE Market"}]},{"@type":"WebSite","@id":"https:\/\/carma.com\/pt-pt\/#website","url":"https:\/\/carma.com\/pt-pt\/","name":"CARMA","description":"Delivering What Matters","publisher":{"@id":"https:\/\/carma.com\/pt-pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/carma.com\/pt-pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/carma.com\/pt-pt\/#organization","name":"CARMA International Inc","url":"https:\/\/carma.com\/pt-pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/carma.com\/pt-pt\/#\/schema\/logo\/image\/","url":"https:\/\/carma.com\/wp-content\/uploads\/2021\/01\/CARMA-Logo.svg","contentUrl":"https:\/\/carma.com\/wp-content\/uploads\/2021\/01\/CARMA-Logo.svg","width":305.23,"height":313.36,"caption":"CARMA International Inc"},"image":{"@id":"https:\/\/carma.com\/pt-pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CARMAGlobal\/","https:\/\/x.com\/CARMA","https:\/\/www.instagram.com\/carmaglobal\/","https:\/\/www.linkedin.com\/company\/carma"]},{"@type":"Person","@id":"https:\/\/carma.com\/pt-pt\/#\/schema\/person\/d9308d8a2da3357eedaaa554e319a674","name":"Puneet Sharma","image":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/secure.gravatar.com\/avatar\/32fe235e639840b91e43ba1712d95201a37faf74f8b7d55f1cebfab1fc131338?s=full&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/32fe235e639840b91e43ba1712d95201a37faf74f8b7d55f1cebfab1fc131338?s=full&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/32fe235e639840b91e43ba1712d95201a37faf74f8b7d55f1cebfab1fc131338?s=full&d=mm&r=g","caption":"Puneet Sharma"}}]}},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/carma.com\/pt-pt\/wp-json\/wp\/v2\/posts\/20102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/carma.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/carma.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/carma.com\/pt-pt\/wp-json\/wp\/v2\/users\/60"}],"replies":[{"embeddable":true,"href":"https:\/\/carma.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=20102"}],"version-history":[{"count":0,"href":"https:\/\/carma.com\/pt-pt\/wp-json\/wp\/v2\/posts\/20102\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/carma.com\/pt-pt\/wp-json\/wp\/v2\/media\/20103"}],"wp:attachment":[{"href":"https:\/\/carma.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=20102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/carma.com\/pt-pt\/wp-json\/wp\/v2\/categories?post=20102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/carma.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=20102"},{"taxonomy":"creator","embeddable":true,"href":"https:\/\/carma.com\/pt-pt\/wp-json\/wp\/v2\/creator?post=20102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}